Molecular Diagnostics for Cancer Market Report 2022:New Diagnostics Create New Markets and New Opportunities
July 06, 2022 05:23 ET
|
Research and Markets
Dublin, July 06, 2022 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization" report...
Global Oncology Partnering 2017-2022: Featuring Key Players AG Mednet, 3B Pharmaceuticals, Abbisko Therapeutics and Others
June 29, 2022 07:58 ET
|
Research and Markets
Dublin, June 29, 2022 (GLOBE NEWSWIRE) -- The "Global Oncology Partnering 2017-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. The Global...
Decibel Therapeutics Reports Positive Data from Interim Analysis of Ongoing Phase 1b Clinical Trial of DB-020 in Patients Receiving Cisplatin Chemotherapy
June 28, 2022 07:00 ET
|
Decibel Therapeutics, Inc.
- 87% of patients who experienced ototoxicity in their placebo-treated ear were protected from ototoxicity in their DB-020-treated ear – - Data support continued development of DB-020 as a potential...
Global Peripheral Neuropathy Treatment Market to Surpass US$ 2,425.9 Million by 2030, Says Coherent Market Insights (CMI)
June 21, 2022 08:40 ET
|
CMI
Seattle, June 21, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global peripheral neuropathy treatment market is estimated to be valued at US$ 1,795.10 million in 2022 and is...
Global $223.21 Billion Oncology Drugs Markets to 2031 with F.Hoffmann-La Roche, Novartis, Gilead Sciences, Bayer and Takeda Pharmacueticals Dominating
June 21, 2022 07:13 ET
|
Research and Markets
Dublin, June 21, 2022 (GLOBE NEWSWIRE) -- The "Oncology Drugs Global Market Report 2022, By Type, Drug Type, Drug Classification" report has been added to ResearchAndMarkets.com's offering. The...
Four Independent Studies of Voraxaze® Published at European Hematology Conference 2022
June 09, 2022 04:49 ET
|
BTG Specialty Pharmaceuticals
Vienna, June 09, 2022 (GLOBE NEWSWIRE) -- The European Hematology Association (EHA) Conference published four independent studies of Voraxaze® (glucarpidase) by various investigators for inclusion...
Global PARP Inhibitors Cancer Therapy Market Outlook 2022-2028: PARP Inhibitors have Proved to be a Commercial Success in the Modern Cancer Therapeutic Segment
June 08, 2022 04:43 ET
|
Research and Markets
Dublin, June 08, 2022 (GLOBE NEWSWIRE) -- The "Global PARP Inhibitors Cancer Therapy Market, Price, Dosage & Clinical Pipeline Outlook 2028" report has been added to ResearchAndMarkets.com's...
Metastatic Breast Cancer Treatment Market worth $41.74 Billion by 2030, Registering a CAGR of 10.4%
June 06, 2022 10:40 ET
|
STRATEGIC MARKET RESEARCH LLP
New York, United States, June 06, 2022 (GLOBE NEWSWIRE) -- Metastatic breast cancer is another word for the advanced form of breast cancer. Breast cancer is a kind of disease in which the breast...
Ovarian Cancer Market to reach a market size of USD 19.92 Billion by 2030 growing at a CAGR of 23.8%: Straits Research
May 30, 2022 12:50 ET
|
Straits Research
New York, United States, May 30, 2022 (GLOBE NEWSWIRE) -- Ovarian cancer drugs are sold to treat ovarian cancer in the Ovarian Cancer Market. The leading cause of ovarian cancer is abnormal cell...
CIPN Market: 5.4% CAGR for Chemotherapy-Induced Peripheral Neuropathy Market Worth $1.17 Billion, Globally, by 2028: The Insight Partners
May 26, 2022 15:07 ET
|
The Insight Partners
New York, May 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Chemotherapy-Induced Peripheral Neuropathy Market Forecast to 2028 - COVID-19 Impact and Global...